Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis

Circulation

Volumn 127, Issue 7, 2013, Pages 842-853

  Koyama, Teruhide ^a   Ochoa Callejero, Laura ^b   Sakurai, Takayuki ^a   Kamiyoshi, Akiko ^a   Ichikawa Shindo, Yuka ^a   Iinuma, Nobuyoshi ^a   Arai, Takuma ^a   Yoshizawa, Takahiro ^a   Iesato, Yasuhiro ^a   Lei, Yang ^a   Uetake, Ryuichi ^a   Okimura, Ayano ^a   Yamauchi, Akihiro ^a   Tanaka, Megumu ^a   Igarashi, Kyoko ^a   Toriyama, Yuichi ^a   Kawate, Hisaka ^a   Adams, Ralf H ^c   Kawakami, Hayato ^d   Mochizuki, Naoki ^e   Martínez, Alfredo ^b   Shindo, Takayuki ^a   more..

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

aging; arteriosclerosis; edema; endothelium; vasculature

Indexed keywords

ACTIN; ADRENOMEDULLIN; GUANOSINE TRIPHOSPHATE; RAC1 PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EDEMA; ENDOTHELIUM CELL; GENE DELETION; GLOMERULOSCLEROSIS; HEART MUSCLE FIBROSIS; HOMEOSTASIS; HYDRONEPHROSIS; LIVER CIRRHOSIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; VASCULARIZATION; VASCULITIS;

ADRENOMEDULLIN; AGE FACTORS; AGING; ANIMALS; ANTIGENS, CD; ARTERIOSCLEROSIS; CADHERINS; DISEASE MODELS, ANIMAL; EDEMA; ENDOTHELIUM, VASCULAR; FIBROSIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HOMEOSTASIS; KIDNEY; LEUKOCYTES; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; VASCULITIS;

EID: 84874107578     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000756     Document Type: Article

References (42)

1. Cleaver O, Melton DA. Endothelial signaling during development. Nat Med. 2003;9:661-668. (Pubitemid 36749214)
2. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9: 653-660. (Pubitemid 36749213)
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
4. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73: 411-418.
5. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192: 553-560. (Pubitemid 23227359)
6. Abe M, Sata M, Nishimatsu H, Nagata D, Suzuki E, Terauchi Y, Kadowaki T, Minamino N, Kangawa K, Matsuo H, Hirata Y, Nagai R. Adrenomedullin augments collateral development in response to acute ischemia. Biochem Biophys Res Commun. 2003;306:10-15. (Pubitemid 36629397)
7. Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J. Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2003;285: H1506-H1514. (Pubitemid 37169504)
8. Isumi Y, Kubo A, Katafuchi T, Kangawa K, Minamino N. Adrenomedullin suppresses interleukin-1beta-induced tumor necrosis factor-alpha production in Swiss 3T3 cells. FEBS Lett. 1999;463:110-114. (Pubitemid 30001728)
9. Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, Fujita T. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation. 2002;105:106-111. (Pubitemid 34049150)
10. Nishikimi T, Matsuoka H. Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure. Curr Med Chem Cardiovasc Hematol Agents. 2005;3:231-242. (Pubitemid 40974783)
11. Petrie MC, Hillier C, Morton JJ, McMurray JJ. Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. J Hypertens. 2000;18:61-64. (Pubitemid 30093709)
12. Samson WK, Murphy T, Schell DA. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology. 1995;136:2349-2352.
13. Shimosawa T, Ogihara T, Matsui H, Asano T, Ando K, Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension. 2003;41:1080-1085. (Pubitemid 36548606)
14. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest. 1994;94:2158-2161. (Pubitemid 24348260)
15. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H. Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol. 1995;26: 1424-1431.
16. Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol. 2009;5:677-689.
17. Shindo T, Kurihara Y, Nishimatsu H, Moriyama N, Kakoki M, Wang Y, Imai Y, Ebihara A, Kuwaki T, Ju KH, Minamino N, Kangawa K, Ishikawa T, Fukuda M, Akimoto Y, Kawakami H, Imai T, Morita H, Yazaki Y, Nagai R, Hirata Y, Kurihara H. Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation. 2001;104:1964-1971. (Pubitemid 32983242)
18. Nagaya N, Mori H, Murakami S, Kangawa K, Kitamura S. Adrenomedullin: angiogenesis and gene therapy. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1432-R1437. (Pubitemid 40720692)
19. Iwase T, Nagaya N, Fujii T, Itoh T, Ishibashi-Ueda H, Yamagishi M, Miyatake K, Matsumoto T, Kitamura S, Kangawa K. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Circulation. 2005;111:356-362. (Pubitemid 40165344)
20. Hanabusa K, Nagaya N, Iwase T, Itoh T, Murakami S, Shimizu Y, Taki W, Miyatake K, Kangawa K. Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats. Stroke. 2005;36:853-858.
21. Iimuro S, Shindo T, Moriyama N, Amaki T, Niu P, Takeda N, Iwata H, Zhang Y, Ebihara A, Nagai R. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ Res. 2004;95:415-423. (Pubitemid 39100460)
22. Maki T, Ihara M, Fujita Y, Nambu T, Miyashita K, Yamada M, Washida K, Nishio K, Ito H, Harada H, Yokoi H, Arai H, Itoh H, Nakao K, Takahashi R, Tomimoto H. Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice. Stroke. 2011;42:1122-1128.
23. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998;393: 333-339. (Pubitemid 28269699)
24. Parameswaran N, Spielman WS. RAMPs: The past, present and future. Trends Biochem Sci. 2006;31:631-638. (Pubitemid 44635265)
25. Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A, Kawate H, Iinuma N, Yoshizawa T, Koyama T, Fukuchi J, Iimuro S, Moriyama N, Kawakami H, Murata T, Kangawa K, Nagai R, Shindo T. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest. 2008;118:29-39.
26. Fernández AP, Serrano J, Tessarollo L, Cuttitta F, Martínez A. Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions. Proc Natl Acad Sci USA. 2008;105: 12581-12586.
27. Minamino T, Yoshida T, Tateno K, Miyauchi H, Zou Y, Toko H, Komuro I. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation. 2003;108:2264-2269. (Pubitemid 37363045)
28. Miyauchi H, Minamino T, Tateno K, Kunieda T, Toko H, Komuro I. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004;23:212-220. (Pubitemid 38165761)
29. Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA. 1994;91:4130-4134. (Pubitemid 24143386)
30. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res. 2009;77:53-63.
31. Fritz-Six KL, Dunworth WP, Li M, Caron KM. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest. 2008;118:40-50.
32. Takahashi H, Watanabe TX, Nishimura M, Nakanishi T, Sakamoto M, Yoshimura M, Komiyama Y, Masuda M, Murakami T. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Hypertens. 1994;7:478-482. (Pubitemid 24170542)
33. Minamino T, Komuro I. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat Clin Pract Cardiovasc Med. 2008;5:637-648.
34. Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007;100:15-26. (Pubitemid 46074968)
35. Longo VD, Finch CE. Evolutionary medicine: from dwarf model systems to healthy centenarians Science. 2003;299:1342-1346. (Pubitemid 36254638)
36. Iinuma N, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Arai T, Yoshizawa T, Koyama T, Uetake R, Kawate H, Muto S, Tagawa Y, Miyagawa S, Shindo T. Adrenomedullin in sinusoidal endothelial cells play protective roles against cold injury of liver. Peptides. 2010;31:865-871.
37. Temmesfeld-Wollbrück B, Hocke AC, Suttorp N, Hippenstiel S. Adrenomedullin and endothelial barrier function. Thromb Haemost. 2007;98:944-951. (Pubitemid 350107695)
38. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol. 2005;25:136-146. (Pubitemid 40039806)
39. Aslam M, Gündüz D, Schuler D, Li L, Sharifpanah F, Sedding D, Piper HM, Noll T. Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1. Cardiovasc Res. 2011;92:276-286.
40. Sano M, Kuroi N, Nakayama T, Sato N, Izumi Y, Soma M, Kokubun S. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens. 2005;18:403-408. (Pubitemid 40409924)
41. Nakazato T, Nakayama T, Naganuma T, Sato N, Fu Z, Wang Z, Soma M, Sugama K, Hinohara S, Doba N. Haplotype-based case-control study of receptor (calcitonin) activity-modifying protein-1 gene in cerebral infarction. J Hum Hypertens. 2010;24:351-358.
42. Bailey RJ, Bradley JW, Poyner DR, Rathbone DL, Hay DL. Functional characterization of two human receptor activity-modifying protein 3 variants. Peptides. 2010;31:579-584.